METASTATIC LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Clinical trials for METASTATIC LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to shrink lung tumors when immunotherapy fails
Disease control OngoingThis study tests a new drug called pevonedistat combined with standard chemotherapy (carboplatin and paclitaxel) in people with advanced non-small cell lung cancer that has not responded to immunotherapy. The goal is to see if this combination can shrink tumors or slow cancer gro…
Matched conditions: METASTATIC LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:40 UTC
-
New drug combo aims to control tough lung cancer
Disease control OngoingThis study tests a new drug (aurora kinase inhibitor) combined with a standard targeted therapy (osimertinib) for people with advanced EGFR-mutant non-small cell lung cancer. The goal is to find the safest dose and see if the combination can better control tumor growth. About 32 …
Matched conditions: METASTATIC LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:27 UTC
-
Could a drug combo outperform chemo for tough lung cancer?
Disease control OngoingThis study tests whether the drug cabozantinib, alone or combined with the immunotherapy nivolumab, works better than standard chemotherapy for people with advanced non-squamous non-small cell lung cancer that has come back after prior treatment. The trial involves 117 adults wit…
Matched conditions: METASTATIC LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:53 UTC